Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Finasteride may cause kidney damage.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

A woman with severe angioedema improved significantly after treatment with rituximab.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.